HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 23, No 10, October 2019 – Disruptive Urban Farming — Microbes, Plasmids, and Recycling       » Chinese scientist find new possibilities in dengue virus control       » 50 young scientists awarded with the inaugural XPLORER PRIZE       » Entering the China market to provide regional support       » Science, Tech, and policies convene for a sustainable future      
EYE ON CHINA
Wuhan Healthgen Biotechnology gains approval for OsrHSA by U.S. FDA
A Wuhan-based biotechnology company in central China's Hubei province received approval by the US Food and Drug Administration for clinical trials of its OsrHSA, a recombinant human serum albumin derived from rice grains.

The clinical trials test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. Approval was announced on 10 August 2019.

It is the first time for a Chinese product of this kind to get the approval, paving the way for the company to enter the US market, according to a report from Hubei Daily.

The human serum albumin is the most abundant protein in human plasma. It can transport hormones, lipids and other molecules while maintaining osmotic pressure, according to the company's official website.

Statistics show in the next few years, the global market demand for human serum albumin is expected to reach 3,800 tons per year, and China's annual demand is forecast to be 700 tons.

Currently, human serum albumin can only be derived from plasma. In 2018, the consumption of serum albumin in China was 468 tons.

According to Healthgen Biotechnology Corp, OsrHSA provides an excellent solution for an animal-free medium, has higher purity and excellent batch consistency, compared with FBS, pHSA and BSA.

OsrHSA is widely used as excipient, stabilizer and embedding agent in bio-pharmaceutical applications, per the company's website.

Yang Daichang, chairman of the company, was quoted by Hubei Daily saying after more than a decade of research and development, the technology has large-scale application value and is expected to replace plasma extraction.

In 2017, OsrHSA entered the human clinical trial stage in China. Previously, researchers completed experiments in rats, monkeys, rabbits and other animals. The results show human serum albumin extracted from rice has no significant difference from human plasma extraction, and by some measures is even better.

Source: China Daily

Click here for the complete issue.

NEWS CRUNCH  
news The Proteona Oncology Challenge using ESCAPETM Single Cell Proteogenomic Analysis
news New computational fluid dynamics solution for modeling aerosol mixtures in biomedical and environmental research
news Medial Fair Thailand opened on 11th September 2019 with a focus on future-proofing Thailand's healthcare industry to meet the challenges and opportunities of the next decade
news Biofuel Producers and Users to Convene in Singapore for Global Biofuels Summit
PR NEWSWIRE  
Asia Pacific Biotech News
SPOTLIGHT  
LIFE OF A SCIENTIST  

APBN Editorial Calendar 2019
January:
Taiwan Medical tourism
February:
Marijuana as medicine — Legal marijuana will open up scientific research
March:
Driven by curiosity
April:
Career developments for researchers
May:
What's cracking — Antibodies in ostrich eggs
June:
Clinical trials — What's in a name?
July:
Traditional Chinese medicine in modern healthcare — Integrating both worlds
August:
Digitalization vs Digitization — Exploring Emerging Trends in Healthcare
September:
Healthy Ageing — How Science is chipping in
October:
Disruptive Urban Farming — Microbes, Plasmids, and Recycling
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy